U.S. unveils new task force aimed at cracking down on illicit e-cigarettes staradvertiser.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from staradvertiser.com Daily Mail and Mail on Sunday newspapers.
An independent advisory panel to the US Food and Drug Administration on Monday gave the green light to Eli Lilly's experimental Alzheimer's drug donanemab. The FDA should vote on approval later this year, STAT reported.
If approved, Eli Lilly's donanemab would become the second Alzheimer's drug of its kind currently on the U.S. market after Leqembi from Biogen and Eisai.
An advisory committee to the Food and Drug Administration found the drug was safe and effective at slowing the progression of the disease, setting the stage for the agency to approve it.
Outside advisers to the Food and Drug Administration on Monday voted unanimously that the benefits of Eli Lilly s experimental Alzheimer s treatment donanemab outweighed its risks, and agreed that trial data